DYNADERM
ActiveSummary
DYNADERM has been active since 2002 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €22k and a net result of €-12k. Equity is growing by ~45.3% per year across the filed fiscal years. Its solvency ranks better than 60% of 18280 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
43
/ 100
Weak
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability0▼-89
Solvency71▼-1
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €500 at 30 days only on tighter terms
Liquidity ample (current ratio 1.86 against 1.88 in 2024; short-term debt: 53.7% and cash: 0.3% of total assets), but 53.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
46.3%
Return on assets
-24.7%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 22-04-2026, 8 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
8 d early
2024
on the day
2023
on the day
2022
88 d late
2021
39 d early
2020
1 d early
2019
on the day
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€22k▼ 34.8%
2024 · €34k
2018: €-13k
2019: €-13k
2020: €-1k
2021: €12k
2022: €36k
2023: €34k
2024: €34k
2018 → 2025
Total assets
€48k▼ 34.1%
2024 · €72k
2018: €11k
2019: €14k
2020: €22k
2021: €59k
2022: €64k
2023: €65k
2024: €72k
2018 → 2025
Net result
€-12k
2024 · €15k
2018: €-4k
2019: €-357
2020: €12k
2021: €13k
2022: €25k
2023: €21k
2024: €15k
2018 → 2025
Working capital
€22k▼ 34.8%
2024 · €34k
2018: €-14k
2019: €-14k
2020: €-1k
2021: €12k
2022: €36k
2023: €34k
2024: €34k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€12k-€36k▲ 209%€34k▼ 6.3%€34k▼ 0.1%€22k▼ 34.8%
Operating result€12k-€28k▲ 131%€12k▼ 58.7%€18k▲ 59.1%€-5k
Net result€13k-€25k▲ 93.5%€21k▼ 17.8%€15k▼ 27.8%€-12k
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result turns negative in 2025: a loss of €5k after €18k in 2024, the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €48k
Equity
€22k ▼ 34.8%
Debt
€26k ▼ 33.5%
Debt's share of the balance-sheet total rises from 53.2% to 53.7%. Equity and debt are lower.
Key figures and ratios
Current ratio
1.86▼
2024 · 1.88
Debt to equity
1.16▲
2024 · 1.14
ROE
-53.4%▼
2024 · 44.2%
ROA
-24.7%▼
2024 · 20.7%
Debt ≤ 1 year
€26k▼
2024 · €38k
Income taxes
€9k▲
2024 · €6k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 35 lines
Balance sheet
Code20242025
Assets
Total assets20/58€72k€48k▼
Current assets29/58€72k€48k▼
Amounts receivable within one year40/41€72k€47k▼
Trade receivables40€9k€14k▲
Other amounts receivable41€63k€33k▼
Cash at bank and in hand54/58€579€130▼
Equity and liabilities
Total equity and liabilities10/49€72k€48k▼
Equity10/15€34k€22k▼
Contributions10/11€19k€19k=
Outside capital11€19k€19k=
Other1109/19€19k€19k=
Profit (loss) carried forward14€15k€3k▼
Amounts payable17/49€38k€26k▼
Amounts payable within one year42/48€38k€26k▼
Trade debts44€15k€22k▲
Suppliers440/4€15k€22k▲
Taxes, remuneration and social security45€8k€3k▼
Taxes450/3€8k€3k▼
Remuneration and social security454/9€800-
Other amounts payable47/48€15k€608▼
Income statement
Code20242025
Other operating charges640/8€1k€493▼
Gross operating margin9900€20k€-4k▼
Operating profit (loss)9901€18k€-5k▼
Financial income75/76B€3k€2k▼
Recurring financial income75€3k€2k▼
Financial charges65/66B€1k€1k▼
Recurring financial charges65€1k€1k▼
Profit (loss) for the period before taxes9903€21k€-3k▼
Income taxes67/77€6k€9k▲
Profit (loss) for the period9904€15k€-12k▼
Profit (loss) for the period to be appropriated9905€15k€-12k▼
Appropriation of the result
Profit (loss) to be appropriated9906€30k€3k▼
Profit (loss) brought forward from the previous period14P€15k€15k▼
Profit to be distributed694/7€15k-
Directors or managers695€15k-
The notes to these accounts (2 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
22-04
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-09
Financial
Weakest financial yearnet €-12k ▼179%
Net result drops to €-12k, the lowest in the series.
30-04
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-04
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
27-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 88 days late
2022
30-09
Financial
Highest result since 2018net €25k ▲93.5%
Operating result €28k, net result €25k, both a record.
22-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
29-04
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
30-09
Financial
Back to profitnet €12k
Net result €12k after 2 loss-making years.
30-04
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
29-04
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
08-05
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 8 days late
2017
09-05
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 9 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wavre · 1 establishment unit since 2003
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Champ des Fontaines 201300 WavreGround area
1,059 m²
Building footprint
98 m²
Volume, LiDAR
1,220 m³
Parcel 25055A0195/00C000, Wallonia · tallest building 24.1 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Champ des Fontaines 20, 1300 Wavre
since 20032.123.438.579
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25055A0195/00C000 | Wallonia | 1,059 m² | 1 · 98 m² | 24.1 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MEDLINX LINA
BE 0696.701.906
Schaarbeek · Eq €21,969
Begis
BE 0790.396.877
Oosterzele · Eq €22,222
APOTHEEK DIRK VAN HERCK
BE 0453.580.413
Nijlen · Eq €21,864
SOBEN Pharma Robeerst
BE 0416.405.162
Esneux · Eq €22,241
Pharmacie Jacqmot
BE 0787.642.770
Sombreffe · Eq €21,849
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 1,581 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded12-12-2002
Fiscal year end30-09
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.